Photo by Joshua Mayo on Unsplash
 

The Chart of the Day belongs to the healthcare company Johnson & Johnson (JNJ). I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum, and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 6/15 the stock gained 1.07%.

(Click on image to enlarge)

JNJ Price vs Daily Moving Averages

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
 

Barchart Technical Indicators:

• 24% technical buy signals
• (6.50) Weighted Alpha
• 7.89% loss in the last year
• Trend Seeker buy signal
• Above its 20, 50, and 100-day moving averages
• 13 new highs and up 5.53% in the last month
• Relative Strength Index 71.58%
• Technical support level at $164.92
• Recently traded at $165.48 with a 50-day moving average of $160.97
   

Fundamental Factors:

• Market Cap $430 billion
• P/E 16.29
• Dividend yield 2.87%
• Revenue is projected to grow 4.20% this year and another 2.30% next year
• Earnings estimated to increase 5.00% this year, an additional 3.20% next year and continue to compound at an annual rate of 4.34% for the next 5 years

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analyst gave 6 strong buy, 2 buy, and 13 hold opinions on the stock
• Analysts price targets are between $161 and $215 with a consensus of $180
• The individual investors on Motley Fool voted 13,604 to 513 for the stock to beat the market with the more experienced investors voting 2,497 to 59 for the same result
• Value Line rates the stock an average rating of 3 and  has an 18-month price target of $184 - 10% above today's price
• CFRAs MarketScope rates it a 4 star hold with a 12-month price target of $168
• 402,950 investors monitor the stock on Seeking Alpha

More By This Author:

Chart Of The Day: Has Verisk Peaked?
Analysts Say Apple Is Done
Chart Of The Day: Broadcom - Reaching New Highs Despite The Analysts